The Carotid Artery Multi-modality Imaging Prognostic (CAMP) Study

Summary

Carotid artery disease is a main cause of ischemic stroke and vascular dementia, and a highly prevalent disease. There is uncertainty about the optimal management of patients with serendipitously or systematically detected asymptomatic carotid artery disease, due to the paucity of information on the predictive features of serious vascular events. While percent diameter stenosis is currently the accepted standard to decide about local interventions (carotid artery stenting or endarterectomy), international guidelines also recommend the evaluation of qualitative features of carotid artery disease as a guide to treatment. There is, however, no agreement on which qualitative features are best predictors of events. Furthermore, a role for metabolic plaque profile, local mechanical and hemorheologic factors in triggering microembolization and silent ischemic events has been proposed from experimental studies. This inadequate knowledge leads to a poor ability to identify patients at higher risk and to an unwarranted dispersion of medical resources, lack of standardization in diagnostic methods, and the use of expensive and resource-consuming techniques.

Against this background, the investigators aim at:

1. Prospectively identifying the best predictors of (silent and overt) ischemic stroke and vascular dementia in patients with asymptomatic subcritical carotid artery disease, by identifying the non-invasive diagnostic features of the "vulnerable carotid plaque" as a possible guide for optimal - local and systemic - treatment.
2. Transferring new ultrasound techniques possibly improving risk prediction to the clinical field
3. Assess whether "smart", low-cost diagnostic methods, such as ultrasound-based evaluations integrating established and advanced techniques, may yield at least the same level of prospective information as more expensive and less cost-effective techniques.

Conditions

• Carotid Artery Diseases
• Carotid Artery Plaque
• Carotid Atherosclerosis

Sponsors & Collaborators

• University of Florence

  collaborator OTHER

• Azienda USL Toscana Nord Ovest

  collaborator OTHER

• Fondazione Toscana Gabriele Monasterio

  collaborator OTHER

• Lund University Hospital

  collaborator OTHER

• University Medical Center Groningen

  collaborator OTHER

• Azienda Ospedaliero, Universitaria Pisana

  lead OTHER

Principal Investigators

• Raffaele De Caterina, MD · Azienda Ospedaliero, Universitaria Pisana

Eligibility

Min Age

45 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2020-10-07

Primary Completion

2023-07-19

Completion

2024-07-19

Countries

• Italy

Study Locations